Clinical Trials Logo

Filter by:
NCT ID: NCT06277934 Active, not recruiting - Obesity Clinical Trials

A Study of RGT001-075 in Adult Patients With Obesity

Start date: March 8, 2024
Phase: Phase 2
Study type: Interventional

This study is being conducted to evaluate RGT001-075 to help people who are above a healthy weight range to lose weight. In this study participants will either get RGT001-075 or a "dummy" medicine (placebo). Which treatment participants get is decided by chance. Participants need to take RGT001-075 or placebo once every day for 12 weeks.

NCT ID: NCT06277323 Active, not recruiting - Cardiology Clinical Trials

UCLA Health Patient Cardiology Care Gaps

Start date: January 30, 2024
Phase: N/A
Study type: Interventional

This is a prospective randomized clinical trial evaluating how two behaviorally-informed interventions (i.e., monthly report card and storyboard interventions) impact physician behavior, with the goal of closing care gaps in preventive care and disease management. In particular, the monthly report card intervention seeks to elevate physicians' intentions to close their patients' care gaps, while the storyboard intervention seeks to prompt action by making patients' care gaps salient. The trial investigates the separate and joint impacts of the proposed behaviorally-informed interventions on encouraging physicians to close their patients' care gaps.

NCT ID: NCT06277310 Active, not recruiting - End of Life Clinical Trials

Implementation of the 3 Wishes Project in Safety-Net Hospitals

Start date: March 19, 2024
Phase: N/A
Study type: Interventional

Dignified and compassionate end-of-life (EOL) care is a cornerstone of high-quality, patient-centered care, but in safety-net hospitals EOL care is often overlooked, considered too late, or not at all. By eliciting and implementing final wishes for dying patients, the 3 Wishes Project (3WP) has demonstrated, in tertiary academic centers, that acts of compassion can improve the EOL experience and help families cope with loss. The investigators propose to implement the 3WP in safety-net hospitals where there are less resources and more diverse, disadvantaged patient populations, and hypothesize that there will be similar positive effects on the EOL experience for patients, families, and clinicians.

NCT ID: NCT06276673 Active, not recruiting - Muscle Edema Clinical Trials

The Influences of Single Chamber vs. Multi-chamber Blood Flow Restriction Cuffs

Start date: February 13, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the use of single (SC) and multi-chamber (MC) blood flow restriction (BFR) cuff exercise on indices of arterial stiffness, muscle morphology, and participant perception.

NCT ID: NCT06276595 Active, not recruiting - Substance Use Clinical Trials

Telling Our Daughters Our Story

TODOS
Start date: March 30, 2019
Phase: N/A
Study type: Interventional

The objective of this research study is to evaluate a culturally grounded program among American Indian (AI) female children and the children's female caregivers. This project will evaluate the impact of "Nowhi Isdza bit Nadagoldi: Telling Our Daughters Our Story (henceforth referred to as TODOS) on associated risk and protective factors for early substance use and sexual debut through a randomized controlled trial on the White Mountain Apache (WMA) reservation. The investigators will examine whether the TODOS program effectively reduces risk factors and improves protective factors associated with early substance use and sexual debut, with long term goals of reducing teen pregnancy and teen substance use.

NCT ID: NCT06276348 Active, not recruiting - Genetic Disease Clinical Trials

Newborn Genomic Sequencing Pilot Study

Start date: March 13, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to test a new method for newborn screening using whole genome sequencing, called BeginNGS. Newborns who are not suspected of having genetic diseases and who are admitted to the NICU at Rady Children's Hospital, San Diego, will be enrolled. The main questions this study aims to answer are: - What is the diagnostic yield of diagnostic whole genome sequencing (DWGS) in this population? - What is the diagnostic sensitivity and specificity of BeginNGS and whole exome sequencing (WES) as compared to DWGS? - What are the potential issues related to implementing DWGS in this population? Enrolled newborns will have a blood sample taken and will receive three tests: - DWGS - BeginNGS - WES

NCT ID: NCT06276036 Active, not recruiting - Cytopenia Clinical Trials

Autoimmune Cytopenias as a Sign of Primary Immunodeficiency.

Start date: July 23, 2019
Phase: N/A
Study type: Interventional

Autoimmune cytopenias resistant to treatment are among the most common clinical manifestations observed in patients with congenital alterations of the immune system, such as primary immunodeficiencies (PI). The exact contribution of immune system alterations to the pathogenesis of autoimmune cytopenias has not yet been fully elucidated. Moreover, conventionally employed therapeutic strategies often fail, leading to increased healthcare costs, high morbidity, and even mortality. Therefore, there is a need to establish clinical guidelines for diagnosis and to identify early biomarkers capable of identifying individuals responsive to therapy. Thus, a systematic approach to the study of such pathologies will allow for the identification of early biomarkers and facilitate the development of targeted therapeutic strategies

NCT ID: NCT06275659 Active, not recruiting - Psoriasis Clinical Trials

An Exploratory Study to Evaluate a Digital Intervention to Disrupt Scratching in Atopic Dermatitis and Psoriasis

Start date: December 4, 2023
Phase: N/A
Study type: Interventional

CT-100 is a platform that provides interactive, software based therapeutic components that may be used as part of a treatment in future software-based prescription digital therapeutics. One class of CT-100 components are Digital Neuro-activation and Modulation (DiNaMo TM) components. DiNaMo components target key neural systems (including but not limited to systems related to sensory-, perceptual-, affective-, pain-, attention-, cognitive control, social- and self- processing) to optimally improve a participant's health.

NCT ID: NCT06275074 Active, not recruiting - Neck Pain Clinical Trials

Dry Needling and Therapeutic Exercise on Sleep in Individuals With Chronic Neck Pain and Sleep Disturbance

Start date: March 14, 2024
Phase: N/A
Study type: Interventional

Feasibility study investigating the effects of dry needling on individuals with chronic neck pain and sleep disturbance.

NCT ID: NCT06274177 Active, not recruiting - Fat Burn Clinical Trials

Evaluation of the BTL-785F Device for Submental Fat Reduction and Neck Rejuvenation

Start date: July 26, 2023
Phase: N/A
Study type: Interventional

This study will evaluate the clinical safety and the performance of the BTL-785F system equipped with the BTL-785-7 applicator for non-invasive reduction of submental fat and skin laxity treatment.